Page last updated: 2024-10-24

carteolol and Angioma

carteolol has been researched along with Angioma in 2 studies

Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.

Angioma: A vascular anomaly due to proliferation of blood or lymphatic vessels that forms a tumor-like mass. Vessels in the angioma may or may not be dilated.

Research Excerpts

ExcerptRelevanceReference
"To report our observations from a trial of the short-term effectiveness and safety of topical carteolol hydrochloride drops to treat infantile hemangiomas (IHs)."9.27A prospective study of topical carteolol therapy in Chinese infants with superficial infantile hemangioma. ( Gan, LQ; Ni, SL; Tan, CH; Wang, H, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gan, LQ1
Wang, H1
Ni, SL1
Tan, CH1
Laaribi, N1
Aachak, M1
Chahdi, H1
Alsubari, A1
Dahi, S1
Abdellaoui, T1
El Asri, F1
Reda, K1
Oubaaz, A1

Trials

1 trial available for carteolol and Angioma

ArticleYear
A prospective study of topical carteolol therapy in Chinese infants with superficial infantile hemangioma.
    Pediatric dermatology, 2018, Volume: 35, Issue:1

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Asian People; Carteolol; Female; Hemangioma; H

2018

Other Studies

1 other study available for carteolol and Angioma

ArticleYear
[Conjunctival hemangioma: From atypical presentation to topical beta-blocker treatment].
    Journal francais d'ophtalmologie, 2018, Volume: 41, Issue:10

    Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Carteolol; Conjunctival Neoplasms; Hema

2018